journal article·2016-09Open access

NF-κB decoy oligodeoxynucleotide mitigates wear particle-associated bone loss in the murine continuous infusion model

Tzu-hua Lin, Jukka Pajarinen, Taishi Sato, Florence Loi, Changchun Fan, Luis A. Córdova, Akira Nabeshima, Emmanuel Gibon, Ruth Zhang, Zhenyu Yao, Stuart B. Goodman

Acta Biomaterialia· Volume 41

Abstract

Unlabelled Total joint replacement is a cost-effective surgical procedure for patients with end-stage arthritis. Wear particle-induced chronic inflammation is associated with the development of periprosthetic osteolysis. Modulation of NF-κB signaling in macrophages, osteoclasts, and mesenchymal stem cells could potentially mitigate this disease. In the current study, we examined the effects of local delivery of decoy NF-κB oligo-deoxynucleotide (ODN) on wear particle-induced bone loss in a murine continuous femoral particle infusion model. Ultra-high molecular weight polyethylene particles (UHMWPE) with or without lipopolysaccharide (LPS) were infused via osmotic pumps into hollow titanium rods placed in the distal femur of mice for 4weeks. Particle-induced bone loss was evaluated by μCT, and immunohistochemical analysis of sections from the femur. Particle infusion alone resulted in reduced bone mineral density and trabecular bone volume fraction in the distal femur. The decoy ODN reversed the particle-associated bone volume fraction loss around the implant, irrespective of the presence of LPS. Particle-infusion with LPS increased bone mineral density in the distal femur compared with particle-infusion alone. NF-κB decoy ODN reversed or further increased the bone mineral density in the femur (3-6mm from the distal end) exposed to particles alone or particles plus LPS. NF-κB decoy ODN also inhibited macrophage infiltration and osteoclast number, but had no significant effects on osteoblast numbers in femurs exposed to wear particles and LPS. Our study suggests that targeting NF-κB activity via local delivery of decoy ODN has great potential to mitigate wear particle-induced osteolysis. Statement of significance Total joint replacement is a cost-effective surgical procedure for patients with end-stage arthritis. Chronic inflammation is crucial for the development of wear particle-associated bone loss. Modulation of NF-κB signaling in macrophages (pro-inflammatory cells), osteoclasts (bone-resorbing cells), and osteoblasts (bone-forming cells) could potentially mitigate this disease. Here we demonstrated that local delivery of decoy NF-κB oligo-deoxynucleotide (ODN) mitigated ultra-high molecular weight polyethylene (UHMWPE) wear particle induced bone loss in a clinically relevant murine model. The protective effects of decoy ODN was associated with reduced macrophage infiltration and osteoclast activation, but had no significant effects on osteoblast numbers. Our study suggests that targeting NF-κB activity via local delivery of decoy ODN has great potential to mitigate wear particle-induced bone loss.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Total Knee Arthroplasty Outcomes · Bone Metabolism and Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Implant Wear Symposium Clinical Work G. What patient and surgical factors contribute to implant wear and osteolysis in total joint arthroplasty?
2. The central role of wear debris in periprosthetic osteolysis10.1007/s11420-006-9003-6 ↗
3. Do genetic susceptibility, Toll-like receptors, and pathogen-associated molecular patterns modulate the effects of wear?10.1007/s11999-014-3786-4 ↗
4. Innate immune reactions in septic and aseptic osteolysis around hip implants10.1615/JLongTermEffMedImplants.2014010564 ↗
5. Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles10.1016/j.biomaterials.2011.04.046 ↗
6. Signaling pathways for tumor necrosis factor-alpha and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro10.2106/00004623-199905000-00002 ↗
7. Revision joint replacement, wear particles, and macrophage polarization10.1016/j.actbio.2012.03.042 ↗
8. NF-kappaB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle
9. Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-kappaB as a therapeutic target10.1016/j.actbio.2013.09.034 ↗
10. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer10.2174/092986707779941113 ↗
11. Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy10.2174/156802612803531397 ↗
12. Suppression of wear-particle-induced pro-inflammatory cytokine and chemokine production in macrophages via NF-kappaB decoy oligodeoxynucleotide: a preliminary report10.1016/j.actbio.2014.04.034 ↗
13. NF-kappaB decoy oligodeoxynucleotide inhibits wear particle-induced inflammation in a murine calvarial model10.1002/jbm.a.35532 ↗
14. Minireview: the OPG/RANKL/RANK system10.1210/endo.142.12.8536 ↗
15. Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis10.1007/s11999-010-1645-5 ↗
16. New treatment of periodontal diseases by using NF-kappaB decoy oligodeoxynucleotides via prevention of bone resorption and promotion of wound healing10.1089/ars.2008.2355 ↗
17. Isolation of predominantly submicron-sized UHMWPE wear particles from periprosthetic tissues10.1002/jbm.820290118 ↗
18. Modulation of mouse macrophage polarization in vitro using IL-4 delivery by osmotic pumps
19. Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin10.1038/sj.bjp.0704803 ↗
20. Effect of a CCR1 receptor antagonist on systemic trafficking of MSCs and polyethylene particle-associated bone loss10.1016/j.biomaterials.2012.02.003 ↗
21. Relationship of acetabular wear to osteolysis and loosening in total hip arthroplasty
22. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model10.1002/jbmr.354 ↗
23. Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling10.1002/stem.1040 ↗
24. The stimulation of an osteogenic response by classical monocyte activation10.1016/j.biomaterials.2011.07.055 ↗
25. Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors10.1186/1471-2121-9-52 ↗
26. Proinflammatory mediators enhance the osteogenesis of human mesenchymal stem cells after lineage commitment10.1371/journal.pone.0132781 ↗
27. Lipopolysaccharide differentially affects the osteogenic differentiation of periodontal ligament stem cells and bone marrow mesenchymal stem cells through Toll-like receptor 4 mediated nuclear factor kappaB pathway10.1186/scrt456 ↗
28. Impact of bacteria and bacterial components on osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells10.1016/j.yexcr.2013.08.020 ↗
29. Adherent lipopolysaccharide inhibits the osseointegration of orthopedic implants by impairing osteoblast differentiation10.1016/j.bone.2012.09.011 ↗
30. Molecular mechanisms of the inhibitory effect of lipopolysaccharide (LPS) on osteoblast differentiation10.1016/j.bbrc.2010.10.103 ↗
31. LPS-induced inhibition of osteogenesis is TNF-alpha dependent in a murine tooth extraction model10.1359/jbmr.090410 ↗
32. New strategies for the treatment of infections associated with prosthetic joints
33. Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy10.2174/156802612803531397 ↗
34. A novel pathway responsible for lipopolysaccharide-induced translational regulation of TNF-alpha and IL-6 expression involves protein kinase C and fascin10.4049/jimmunol.1100612 ↗
35. Mutant MCP-1 protein delivery from layer-by-layer coatings on orthopedic implants to modulate inflammatory response10.1016/j.biomaterials.2013.09.028 ↗
36. The future of biologic coatings for orthopaedic implants10.1016/j.biomaterials.2013.01.074 ↗
37. Regulation of tissue factor expression in brain microvascular endothelial cells by PLA nanoparticles coating NF-kappaB decoy oligonucleotides
38. Local administration of NF-kappa B decoy oligonucleotides to prevent restenosis after balloon angioplasty: an experimental study in New Zealand white rabbits10.1007/s00270-003-0239-y ↗
39. Long-term controlled protein release from poly(ethylene glycol) hydrogels by modulating mesh size and degradation10.1002/mabi.201500245 ↗
40. Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides10.1021/bc200377d ↗
41. Controlling systems of nucleic acid sensing-TLRs restrict homeostatic inflammation10.1016/j.yexcr.2012.03.032 ↗
42. Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein10.1038/nm0497-414 ↗
43. Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers10.1016/j.biomaterials.2014.10.036 ↗